Laboratorios Farmaceuticos Forecast, price target & analysts
Laboratorios Farmaceuticos Target price 2025 - Analyst rating & recommendation
Laboratorios Farmaceuticos Classifications & Recommendation:
Laboratorios Farmaceuticos Price Target
| Target Price | €79.15 |
| Price | €64.40 |
| Potential |
22.91%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target Laboratorios Farmaceuticos 2026 .
The average Laboratorios Farmaceuticos target price is €79.15.
This is
22.91%
register free of charge
€96.60
50.00%
register free of charge
€65.95
2.41%
register free of charge
|
|
| A rating was issued by 15 analysts: 11 Analysts recommend Laboratorios Farmaceuticos to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Laboratorios Farmaceuticos stock has an average upside potential 2026 of
22.91%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million € | 763.75 | 741.65 |
| 7.93% | 2.89% | |
| EBITDA Margin | 27.18% | 26.55% |
| 7.83% | 2.31% | |
| Net Margin | 17.92% | 17.70% |
| 12.72% | 1.24% |
10 Analysts have issued a sales forecast Laboratorios Farmaceuticos 2025 . The average Laboratorios Farmaceuticos sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an Laboratorios Farmaceuticos EBITDA forecast 2025. The average Laboratorios Farmaceuticos EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 Laboratorios Farmaceuticos Analysts have issued a net profit forecast 2025. The average Laboratorios Farmaceuticos net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share € | 2.67 | 2.57 |
| 16.56% | 3.75% | |
| P/E | 25.09 | |
| EV/Sales | 4.51 |
10 Analysts have issued a Laboratorios Farmaceuticos forecast for earnings per share. The average Laboratorios Farmaceuticos EPS is
This results in the following potential growth metrics and future valuations:
Laboratorios Farmaceuticos...
Current Laboratorios Farmaceuticos Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JEFFERIES |
Locked
➜
Locked
|
Locked | Aug 13 2025 |
| ALANTRA EQUITIES |
Locked
➜
Locked
|
Locked | Aug 11 2025 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Jul 25 2025 |
| BANCO SANTANDER |
Locked
➜
Locked
|
Locked | Jul 24 2025 |
| ANALISIS BANCO SABADELL |
Locked
➜
Locked
|
Locked | Jul 24 2025 |
| BANCO SANTANDER |
Locked
➜
Locked
|
Locked | Jul 17 2025 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Jul 17 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Aug 13 2025 |
|
Locked
ALANTRA EQUITIES:
Locked
➜
Locked
|
Aug 11 2025 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Jul 25 2025 |
|
Locked
BANCO SANTANDER:
Locked
➜
Locked
|
Jul 24 2025 |
|
Locked
ANALISIS BANCO SABADELL:
Locked
➜
Locked
|
Jul 24 2025 |
|
Locked
BANCO SANTANDER:
Locked
➜
Locked
|
Jul 17 2025 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Jul 17 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
